Read More

Stocks Falter Ahead Of Data-Rich Week, Tesla Rallies On ‘Robotaxi’ Push, Bitcoin Reclaims $71,500: What’s Driving Markets Monday?

It’s a lackluster trading session on Wall Street, with the main indices experiencing slight declines as traders adopt a cautious stance ahead of a data-heavy week.

AIRC

Read More

Bristol Myers’ $14B Bet On Schizophrenia – Drug Cuts Symptoms Without Common Side Effect Of Weight Gain Associated With Other Antipsychotics

Interim data from Bristol Myers Squibb's Phase 3 EMERGENT program on KarXT's safety, tolerability, and metabolic outcomes in adults with schizophrenia. Find out how KarXT demonstrated favorable impacts on weight and long-term metabolic profile over 52 weeks of treatment.

BMY

Read More

Stocks Rally On Hot Jobs Data, Defy Interest Rate Fears, Gold Hits New High, Oil Tops $87: What’s Driving Markets Friday?

It’s a day of broad-based rallies on Wall Street, with both stocks and commodities showcasing robust performances in the wake of a hotter-than-expected labor market report, seemingly unfazed by growing fears over delays in the Federal Reserve’s rate cut plans.

BTC